Vaxcyte, Inc. PCVX Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s change in AP?
- Vaxcyte, Inc. (PCVX) reported change in AP of -$269K in Q1 2026.
- How has Vaxcyte, Inc.'s change in AP changed year-over-year?
- Vaxcyte, Inc.'s change in AP increased by 99.1% year-over-year, from -$29.16M to -$269K.
- What is the long-term trend for Vaxcyte, Inc.'s change in AP?
- Over 3 years (2021 to 2024), Vaxcyte, Inc.'s change in AP has grown at a 40.5% compound annual growth rate (CAGR), from -$12.47M to $34.58M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.